摘要:
The present invention describes novel thiazolo[4,5-d]pyrimidines of formula (I), or a pharmaceutically acceptable salt thereof, wherein X is CR4 or N; Y is selected from the group: S, O and NR5; R1 is selected from the group: H, C¿1-4? alkyl, C2-4 alkenyl, C2-4 alkynyl, Cl, F, Br, I, -CN, C1-5 haloalkyl, -NR?6R7, -NR6COR7, -OR8¿, -SH, and -S(O)¿nR?9; R2 is selected from the group: -CR?10R11R12, -NR10aR11a, -NHCR10R11R12, -OCR10R11R12¿, and phenyl, wherein the phenyl is substituted with 0-4 Ra; R3 is selected from the group: phenyl, pyridyl, pyrimidyl, napthyl, triazinyl, furanyl, quinolinyl, isoquinolinyl, thienyl, thiazolyl, pyrrolyl, oxazolyl, benzofuranyl, benzothienyl, benzothiazolyl, isoxazolyl, and pyrazolyl, and is substituted with 1 to 4 Rb groups; R4 is selected from the group: H, C¿1-4? alkyl, and C1-4 haloalkyl, halogen, NH2, NH(C1-4 alkyl), NH(C1-4 alkyl)2, CN, OR?8; and R5¿ is -CO(C¿1-4? alkyl) or -CO2(C1-4 alkyl), which are useful as CRF antagonists.
摘要:
Novel compounds and pharmaceutical compositions thereof, and methods of using same in treating anxiety, depression, and other psychiatric and neurological disorders. The novel compounds provided by this invention are those of formulae (I), (II) wherein R1, R13, X, Y, Z, G and Q are as defined herein.
摘要:
Corticotropin releasing factor (CRF) antagonists of formula (I) or formula (II): and their use in treating anxiety, depression, and other psychiatric and neurological disorders.